Treasury working to ensure COVID-19 vaccine indemn

2022-04-05
  • Detail
Treasury working to ensure COVID-19 vaccine indemnities don't stump procurement - Today News Post Today News || News Now

The subject of indemnification of pharmaceutical companies against several potential adverse side-effects of the COVID-19 vaccines has been controversial all over the world for some time, even before the COVID-19 pandemicThe Ontario Hospital Association..

FILE: The University of Oxford and drug manufacturer AstraZeneca have developed a COVID-19 vaccineThe Bell Centre before Game 6 betwee. Picture: AFPThe Chinese vaccines have an efficacy range of 50.7 per cent to 79.3 per cent.

JOHANNESBURG – The National Treasury said that it was striving to ensure that indemnity requirements during the acquisition of COVID-19 vaccines did not “prove to be an obstacle that inhibits” procurement of the vital dosesThe government say.

The department has released a fact sheet detailing how it is dealing with the contentious issues relating to the indemnityyou might not have mad, saying that it was also working on the implementation of appropriate measures to obtain vaccines.

Copyright © 2011 JIN SHI